ADMA Competitors & Alternatives
Compare ADMA Biologics Inc with similar stocks in the same industry
Biotechnology
ADMA
Main Stock$9.84
Tradestie Score
40
Market Cap
$3.59B
P/E Ratio
13.9
Revenue Growth
0.2%
Analyst Upside
+72.8%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$134.75
|
$2.35B | - | 56 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.79
|
$2.34B | - | 43 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$79.81
|
$2.33B | - | 50 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$33.09
|
$2.33B | - | 56 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 46 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.50
|
$2.23B | - | 42 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.99
|
$2.22B | - | 50 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$65.71
|
$2.21B | - | 36 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$24.92
|
$2.18B | - | 50 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$17.00
|
$2.08B | - | 38 | Compare |
More ADMA Analysis
Data updated: Aug 22, 2026 | Industry: Biotechnology (SIC 2836)
238 stocks in this industry